Navigation Links
Cephalon Announces that FDA Grants Priority Review of its Supplemental New Drug Application for NUVIGIL as a Treatment for Excessive Sleepiness Associated with Jet Lag Disorder
Date:9/24/2009

_new' target='_new' href="http://www.cephalon.com/" target="_new">www.cephalon.com or by calling 1-800-896-5855.

In addition to historical facts or statements of current condition, this press release may contain forward-looking statements. Forward-looking statements provide Cephalon's current expectations or forecasts of future events. These may include statements regarding anticipated scientific progress on its research programs, development of potential pharmaceutical products, interpretation of clinical results, clinical development of NUVIGIL, timing of FDA decisions, prospects for regulatory approval, manufacturing development and capabilities, market prospects for its products, sales and earnings guidance, and other statements regarding matters that are not historical facts. You may identify some of these forward-looking statements by the use of words in the statements such as "anticipate," "estimate," "expect," "project," "intend," "plan," "believe" or other words and terms of similar meaning. Cephalon's performance and financial results could differ materially from those reflected in these forward-looking statements due to general financial, economic, regulatory and political conditions affecting the biotechnology and pharmaceutical industries as well as more specific risks and uncertainties facing Cephalon such as those set forth in its reports on Form 8-K, 10-Q and 10-K filed with the U.S. Securities and Exchange Commission. Given these risks and uncertainties, any or all of these forward-looking statements may prove to be incorrect. Therefore, you should not rely on any such factors or forward-looking statements. Furthermore, Cephalon does not intend to update publicly any forward-looking statement, except as required by law. The Private Securities Litigation Reform Act of 1995 permits this discussion.

    Contacts:

    Media
    Sheryl Williams
    610-738-6493
    '/>"/>
SOURCE Cephalon, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder
2. Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia
3. Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder
4. Cephalon Announces Positive Results From a Phase Two Study of NUVIGIL in Bipolar Depression
5. Cephalon Signs Option Agreement to Acquire Ception Therapeutics
6. Cephalon Receives Complete Response Letter Regarding Request for Expanded FENTORA Label for Non-Cancer Breakthrough Pain
7. Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkins Lymphoma
8. Cephalon Announces Positive Results from Its Pivotal Study of TREANDA in Patients with Non-Hodgkins Lymphoma
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. Pres. Clinton Announces Commitment From Inter-American Development Bank, Global Network for Neglected Tropical Diseases, and Pan American Health Organization to Mobilize $30 Million to Fight NTDs in the Americas at CGI Conference
11. Sangamo BioSciences Announces Plans to Initiate a Second Clinical Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... DIEGO , July 29, 2015  ViaCyte, Inc., a privately-held ... for the treatment of diabetes in clinical trials, today announced the ... STEP ONE, or S afety, T olerability, and ... One Diabetes.  The new site, which is the first in ... Alberta Hospitals in Edmonton , Alberta.  ...
(Date:7/29/2015)... , July 29, 2015 ... Market Research " Active Pharmaceutical Ingredients (API) Market - ... 2014 - 2020 " the global active pharmaceutical ingredients ... and is anticipated to reach USD 185.9 billion by ... forecast period from 2014 to 2020. Full ...
(Date:7/29/2015)... 29, 2015   Decision Resources Group finds ... Europe will continue to be hindered in ... Eurozone. On a longer timeline, however, the outlook is ... active will increase the prevalence of osteoarthritic damage and ... orthopedic soft tissue solutions. Coupled with continuing economic recovery ...
Breaking Medicine Technology:ViaCyte Announces Second Clinical Trial Site at University of Alberta 2ViaCyte Announces Second Clinical Trial Site at University of Alberta 3ViaCyte Announces Second Clinical Trial Site at University of Alberta 4Active Pharmaceutical Ingredients Market Expected to Reach USD 185.9 Billion Globally in 2020: Transparency Market Research 2Active Pharmaceutical Ingredients Market Expected to Reach USD 185.9 Billion Globally in 2020: Transparency Market Research 3Active Pharmaceutical Ingredients Market Expected to Reach USD 185.9 Billion Globally in 2020: Transparency Market Research 4Active Pharmaceutical Ingredients Market Expected to Reach USD 185.9 Billion Globally in 2020: Transparency Market Research 5The Long-Term Outlook for European Sports Medicine Device Markets Remains Positive, with Economic Recovery and Expanding Patient Populations Supporting Growth Through 2023 2The Long-Term Outlook for European Sports Medicine Device Markets Remains Positive, with Economic Recovery and Expanding Patient Populations Supporting Growth Through 2023 3
... Jan. 3, 2011 Accuray Incorporated (Nasdaq: ... radiosurgery, announced today that it has been named to the ... companies. The NASDAQ Global Select Market is designated for public ... with measures including market value, liquidity and earnings. ...
... Dec. 31, 2010 On January 1, 2011, ... durable medical equipment and supplies in nine metropolitan ... Miami, Orlando, Pittsburgh, and Riverside, California.  This program ... the following equipment and related services and supplies: ...
Cached Medicine Technology:Accuray Elevated to NASDAQ Global Select Market 2Accuray Elevated to NASDAQ Global Select Market 3Complaints and Concerns about Medicare Competitive Bidding for Home Medical Equipment Can Be Reported Via a Toll-Free Number and Website 2Complaints and Concerns about Medicare Competitive Bidding for Home Medical Equipment Can Be Reported Via a Toll-Free Number and Website 3
(Date:7/29/2015)... ... , ... Employee Fiduciary, LLC announces the launch of its new, online Financial ... plans administered, years in business, and credentials of all Employee Fiduciary financial advisor ... Employee Fiduciary. A search can be done by zip code so a plan sponsor ...
(Date:7/29/2015)... IL (PRWEB) , ... July 29, 2015 , ... Several ... ever-expanding population of children with autism, Little City took a proactive stance and began ... occupied. The Coleman Foundation grant provides valuable support to building the third home. , ...
(Date:7/29/2015)... Louis, MO (PRWEB) , ... July 29, 2015 , ... ... website, the Talcum Powder Cancer Lawsuit Center. The website now features a page dedicated ... and news pieces from other sources. The Talcum Powder Lawsuit News page ...
(Date:7/29/2015)... ... 29, 2015 , ... Toronto native Douglas James Cottrell, Ph.D., ... has been making predictions about the economy, politics, social issues, as well as ... He warns that extreme weather conditions and increased earthquake / volcanic activity will ...
(Date:7/29/2015)... ... July 29, 2015 , ... " mybody ” was featured on NewsWatch ... and large businesses making an impact in their industry. Andrew Tropeano, the host of ... advanced probiotic skincare products are designed to strengthen the skin’s defense system from the ...
Breaking Medicine News(10 mins):Health News:Employee Fiduciary Launches Financial Advisor Directory 2Health News:Little City Receives $500,000 Matching Grant from The Coleman Foundation 2Health News:Little City Receives $500,000 Matching Grant from The Coleman Foundation 3Health News:National Attorneys Provide Regular Talcum Powder Lawsuit News Updates 2Health News:National Attorneys Provide Regular Talcum Powder Lawsuit News Updates 3Health News:Author Warns Public to Prepare for Imminent Environmental Disaster 2Health News:Strengthen the Skin’s Defense System from the Inside Out with mybody 2
... record ... project to benefit patients, CLEVELAND, July 9 ... suite, announced that SSM,Health Care has experienced immediate results since ... and offering services in four,states, SSM is a forward-thinking health ...
... 9 SKINTASTIC(TM),Medical and Surgical Rejuvenation Center is ... -- the latest injectable collagen filler,in the Skintastic ... immediate, predictable visible results, with little,swelling. Less bruising ... a,comparison study against a popular dermal filler., ...
... its unparalleled content on breastfeeding with, the ... child, health, from allergies and infections to ... Colo., July 9 Breastfeeding.com, a premier,online ... improves its already,unparalleled content on breastfeeding with ...
... Disaboom reveals that majority of Americans think life with a severe ... ... (PRWEB) July 9, 2008 -- 52 percent of Americans would rather ... national survey commissioned by Disaboom (OTCBB: DSBO; www.disaboom.com ...
... InsuranceSpecialists.com, a leader in online insurance data and free ... information to help voters understand the position presidential candidates ... The site, which is advertisement-free, supplies unbiased material on ... consumers make the best choices in coverage for themselves ...
... Bag II is an integrated sales tool designed for ... new Detail Bag II (DB2) is 25 percent smaller ... thin, lighter "road ready" sample case was inspired ... of a high-denier luggage grade material with a steel ...
Cached Medicine News:Health News:SSM Health Care Upgrades Patient Care With Speedy Document Management Implementation 2Health News:SSM Health Care Upgrades Patient Care With Speedy Document Management Implementation 3Health News:New Injectable Collagen Filler Offers Natural Results 2Health News:Breastfeeding.com Becomes a Premier Resource on Child Health 2Health News:Disaboom Survey Reveals 52 Percent of Americans Would Rather be Dead Than Disabled 2Health News:Disaboom Survey Reveals 52 Percent of Americans Would Rather be Dead Than Disabled 3Health News:Disaboom Survey Reveals 52 Percent of Americans Would Rather be Dead Than Disabled 4Health News:InsuranceSpecialists.com Looks at the Candidates and Health Reform 2Health News:InsuranceSpecialists.com Looks at the Candidates and Health Reform 3Health News:Texas Detailed Products Today Announced the Second Generation Detail Bag: Skinceuticals Chooses the Detail Bag II Sample Case for all its Pharmaceutical Representatives 2Health News:Texas Detailed Products Today Announced the Second Generation Detail Bag: Skinceuticals Chooses the Detail Bag II Sample Case for all its Pharmaceutical Representatives 3
Therapeutic Drug Calibrator Series...
The IRN method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of iron in serum....
The AST method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of aspartate aminotransferase activity in serum or plasma...
For the quantitative in vitro determination of Aspartate Aminotransferase (AST) in serum and plasma....
Medicine Products: